订阅小程序
旧版功能

Try: A Phase Ii Study to Evaluate Safety and Efficacy of Combined Trastuzumab and Auy922 in Advanced Non-Small-Cell Lung Cancer (nsclc) with Her2 Overexpression or Amplification or Mutation

L. Nogova,M. Gardizi,M. Bos,M. Scheffler,I. Papachristou,C. Woempner,L. Heukamp,H. -U. Schildhaus,U. Fuhr,M. Sos,W. Eberhardt,M. Wiesweg,K. W. Schmid,M. Schuler,R. Thomas,R. Buettner,J. Wolf

Journal of Clinical Oncology（2014）

引用 6|浏览52
关键词
HER2,trastuzumab,AUY922
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要